Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greta Celesti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 19, 2026
The predictive role of [<sup>177</sup>Lu]Lu-PSMA-617 SPECT/CT semiquantitative parameters from the 1st RLT cycle in advanced mCRPC: a preliminary bicentric lesion-based analysisRiccardo Laudicella, Greta Celesti, Matteo Bauckneht, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other RadiopharmaceuticalsAlberto Miceli, Virginia Liberini, Giovanna Pepe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2025
[<sup>18</sup>F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patientsMatteo Bauckneht, Giovanni Pasini, Tania Di Raimondo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 3, 2026
Is there a role for early SSTR-targeting PRRT in GEP-NET?Giorgia Ricciardello, Greta Celesti, Matteo Bauckneht, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Preliminary Findings of the Role of FAPi in Prostate Cancer TheranosticsRiccardo Laudicella, Alessandro Spataro, Ludovica Crocè, et al.
European Urology Oncology|April 30, 2025
Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography/Computed TomographyFrancesca Ambrosini, Nataniele Piol, Matteo Bauckneht, et al.
Cancers|February 24, 2024
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the LiteraturePriscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Cancers|July 12, 2025
Interpretation of PSMA-PET Among Urologists: A Prospective Multicentric EvaluationGuglielmo Mantica, Francesco Chierigo, Francesca Ambrosini, et al.
Life (Basel, Switzerland)|September 28, 2023
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the LiteraturePriscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|May 19, 2026
The predictive role of [<sup>177</sup>Lu]Lu-PSMA-617 SPECT/CT semiquantitative parameters from the 1st RLT cycle in advanced mCRPC: a preliminary bicentric lesion-based analysisRiccardo Laudicella, Greta Celesti, Matteo Bauckneht, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other RadiopharmaceuticalsAlberto Miceli, Virginia Liberini, Giovanna Pepe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2025
[<sup>18</sup>F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patientsMatteo Bauckneht, Giovanni Pasini, Tania Di Raimondo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 3, 2026
Is there a role for early SSTR-targeting PRRT in GEP-NET?Giorgia Ricciardello, Greta Celesti, Matteo Bauckneht, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Preliminary Findings of the Role of FAPi in Prostate Cancer TheranosticsRiccardo Laudicella, Alessandro Spataro, Ludovica Crocè, et al.
European Urology Oncology|April 30, 2025
Immunohistochemical Prostate-specific Membrane Antigen (PSMA) Expression Patterns of Primary Prostate Cancer Tissue as a Determining Factor for Prostate Cancer Staging with PSMA Positron Emission Tomography/Computed TomographyFrancesca Ambrosini, Nataniele Piol, Matteo Bauckneht, et al.
Cancers|February 24, 2024
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the LiteraturePriscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Cancers|July 12, 2025
Interpretation of PSMA-PET Among Urologists: A Prospective Multicentric EvaluationGuglielmo Mantica, Francesco Chierigo, Francesca Ambrosini, et al.
Life (Basel, Switzerland)|September 28, 2023
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the LiteraturePriscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, et al.
Pageof 1